attachment
attachment
attachment
attachment

40 year female with BCVA 6/12, BOTH EYES, ATTACHED IS TGE TOPOGRAPHY. What should be the next step in the management?

Reading File
analyse_media
analyse_media
Now let me search the medical library for keratoconus management guidance while also running a PubMed search in parallel.
Finding Sources
Searching PubMed

keratoconus management corneal collagen crosslinking

Finding Sources
Reading File
Reading File
Reading File
Reading File
Now let me get the full keratoconus management section from Kanski's for the CXL criteria and contact lens details:
Reading File
Reading File
I now have all the data needed. Let me synthesize a comprehensive answer.

Topography Interpretation + Next Steps

What the Topography Shows

Both eyes (OU) - Scheimpflug Corneal Mapping (Pentacam-type)
OS (Left Eye) - Confirmed Keratoconus:
  • K readings (anterior): K-flat 44.60 D @ 153°, K-steep 48.65 D @ 63°, SimK steep 49.75 D @ 57°
  • K-max: 51.09 D - indicating moderate-to-advanced keratoconus (>48 D = moderate; >54 D = severe)
  • Corneal thickness minimum (Thk-min: 401 µm) - significantly thinned
  • Posterior elevation: markedly elevated (hot spot on posterior elevation map)
  • Anterior elevation: focal area of high positive elevation
  • Keratoconus Screening classification: KERATOCONUS (red flags on all curvature indices - SIf, CSIf, SIb, CSIb all red-dotted)
  • Tangential curvature map: Classic inferior-paracentral steepening cone pattern
OD (Right Eye) - Confirmed Keratoconus:
  • K readings (anterior): K-flat 44.71 D @ 26°, K-steep 50.63 D @ 116°, SimK steep 52.90 D
  • K-max: 54.42 D - severe keratoconus range
  • Corneal thickness minimum (Thk-min: 384 µm) - severely thinned
  • Posterior elevation: dramatically elevated (large area of high positive posterior elevation, values >+283 µm visible)
  • Keratoconus screening: KERATOCONUS (all indices red-dotted)
  • Classification: Keratoconus, more advanced than OS
Summary: Bilateral keratoconus - OD more severe (K-max ~54 D, Thk-min 384 µm), OS moderate-severe (K-max ~51 D, Thk-min 401 µm). Both eyes show significant posterior elevation, anterior elevation, and marked corneal thinning consistent with the device's own "Keratoconus" classification.

Next Steps in Management

Step 1 - Immediate: Assess for Progression (Most Critical)

The most important question before any intervention is: Is the keratoconus progressive?
  • Obtain serial topographies (compare with any prior Pentacam/Orbscan maps). Progression is defined as:
    • Increase in K-max of ≥1.0 D over 12 months
    • Decrease in minimum corneal thickness of ≥2% over 12 months
    • Increase in manifest cylinder
    • Worsening BCVA
  • If this is the first topography, repeat it in 3-6 months to establish progression. However, given the patient's age (40 years), the BCVA (6/12 both eyes), and the severity on the maps, the clinical priority below still holds.

Step 2 - Corneal Cross-Linking (CXL) Assessment

Given bilateral confirmed keratoconus with reduced BCVA (6/12 OU), CXL should be strongly considered:
  • CXL is indicated if progression is documented (or suspected given no prior data and this severity at age 40)
  • Standard Dresden protocol (epithelium-off): 9 mm epithelial debridement, riboflavin 0.1% drops for 30 min, then UVA 365 nm at 3 mW/cm² for 30 min (5.4 J/cm² total)
  • Minimum corneal thickness requirement: ≥400 µm (after epithelial removal/swelling)
    • OS: Thk-min 401 µm - borderline, may need hypo-osmolar riboflavin to swell the stroma to ≥400 µm before UVA
    • OD: Thk-min 384 µm - below the conventional safe threshold. Accelerated or modified protocols, or hypoosmolar riboflavin pre-treatment to achieve ≥400 µm, must be used. This is a critical safety consideration.
  • CXL is successful in halting progression in >90% of cases and can even partially reverse ectasia (Kanski's Clinical Ophthalmology, 10th ed.)

Step 3 - Visual Rehabilitation

The patient currently sees 6/12 (20/40) OU with best-corrected vision. Management of vision:
  1. Spectacles - Useful if the irregular astigmatism is not too severe. Given the K values, spectacles alone may be insufficient for best acuity.
  2. Rigid Gas Permeable (RGP) contact lenses - First-line for moderate keratoconus. Vaults the irregular cone and provides a regular refracting surface.
  3. Scleral contact lenses - Better option for advanced/irregular cases; vaults the cone entirely, very well tolerated.
  4. Hybrid lenses or piggyback lenses - Alternatives if RGP tolerance is poor.
Given this patient has moderate-severe bilateral KC with 6/12 BCVA, an RGP or scleral lens trial should be done to determine if BCVA improves with a regular refracting surface. If BCVA improves significantly with RGP/scleral lenses, visual rehabilitation is the priority alongside stabilization.

Step 4 - Counseling

  • Strict no-eye-rubbing counseling - This is non-negotiable. Eye rubbing is a major risk factor for progression.
  • Treat any associated atopy/allergy aggressively (antihistamines, mast cell stabilizers)
  • Genetic counseling awareness - 10% risk in offspring

Step 5 - If Contact Lenses Fail (Advanced Disease Management)

  • Intracorneal ring segments (ICRS) - e.g., Intacs, Ferrara rings. Can regularize the cornea and improve contact lens tolerance. Can be combined with CXL ("ICRS + CXL" or "corneal remodeling + stabilization" approach).
  • Keratoplasty (if contact lenses are not tolerated and disease is too advanced):
    • DALK (Deep Anterior Lamellar Keratoplasty) - preferred; preserves host endothelium, lower rejection risk
    • PKP (Penetrating Keratoplasty) - reserved for cases with endothelial compromise or prior hydrops with Descemet membrane rupture
    • Note: LASIK is absolutely contraindicated in keratoconus

Recommended Action Plan Summary

PriorityActionRationale
1Slit-lamp exam (Vogt striae, Fleischer ring, scarring, hydrops)Complete clinical picture
2Review/obtain prior topographies to confirm progressionDefines CXL urgency
3Trial of RGP or scleral contact lensesImprove BCVA 6/12
4CXL - plan for both eyes (OD caution re: 384 µm)Halt progression
5Strict no-rubbing + allergy managementPrevent acceleration
Key point for OD: The minimum corneal thickness of 384 µm in OD is below the standard CXL safety threshold of 400 µm. Hypo-osmolar riboflavin protocol or alternative accelerated CXL protocols should be considered and discussed with a corneal specialist before proceeding.

Sources: Kanski's Clinical Ophthalmology: A Systematic Approach, 10th ed. - Wills Eye Manual, 8th ed. | Recent evidence: Epithelium-on vs epithelium-off CXL meta-analysis 2025 (PMID 40856685)
This is a shared conversation. Sign in to Orris to start your own chat.